Brain imaging and networks in restless legs syndrome

Giovanni Rizzo, Xu Li, Sebastiano Galantucci, Massimo Filippi, Yong Won Cho

Research output: Contribution to journalReview article

23 Citations (Scopus)

Abstract

Several studies provide information useful to our understanding of restless legs syndrome (RLS), using various imaging techniques to investigate different aspects putatively involved in the pathophysiology of RLS, although there are discrepancies between these findings. The majority of magnetic resonance imaging (MRI) studies using iron-sensitive sequences supports the presence of a diffuse, but regionally variable low brain-iron content, mainly at the level of the substantia nigra, but there is increasing evidence of reduced iron levels in the thalamus. Positron emission tomography (PET) and single positron emission computed tomography (SPECT) findings mainly support dysfunction of dopaminergic pathways involving not only the nigrostriatal but also mesolimbic pathways. None or variable brain structural or microstructural abnormalities have been reported in RLS patients; reports are slightly more consistent concerning levels of white matter. Most of the reported changes were in regions belonging to sensorimotor and limbic/nociceptive networks. Functional MRI studies have demonstrated activation or connectivity changes in the same networks. The thalamus, which includes different sensorimotor and limbic/nociceptive networks, appears to have lower iron content, metabolic abnormalities, dopaminergic dysfunction, and changes in activation and functional connectivity. Summarizing these findings, the primary change could be the reduction of brain iron content, which leads to dysfunction of mesolimbic and nigrostriatal dopaminergic pathways, and in turn to a dysregulation of limbic and sensorimotor networks. Future studies in RLS should evaluate the actual causal relationship among these findings, better investigate the role of neurotransmitters other than dopamine, focus on brain networks by connectivity analysis, and test the reversibility of the different imaging findings following therapy.

Original languageEnglish
Pages (from-to)39-48
Number of pages10
JournalSleep Medicine
Volume31
DOIs
Publication statusPublished - Mar 1 2017

Fingerprint

Restless Legs Syndrome
Neuroimaging
Iron
Brain
Thalamus
Positron-Emission Tomography
Magnetic Resonance Imaging
Substantia Nigra
Neurotransmitter Agents
Dopamine

Keywords

  • Connectivity
  • Imaging
  • MRI
  • Network
  • Pathophysiology
  • Restless legs syndrome

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Brain imaging and networks in restless legs syndrome. / Rizzo, Giovanni; Li, Xu; Galantucci, Sebastiano; Filippi, Massimo; Cho, Yong Won.

In: Sleep Medicine, Vol. 31, 01.03.2017, p. 39-48.

Research output: Contribution to journalReview article

Rizzo, Giovanni ; Li, Xu ; Galantucci, Sebastiano ; Filippi, Massimo ; Cho, Yong Won. / Brain imaging and networks in restless legs syndrome. In: Sleep Medicine. 2017 ; Vol. 31. pp. 39-48.
@article{03826a5b2d074659bdef71ecb230868a,
title = "Brain imaging and networks in restless legs syndrome",
abstract = "Several studies provide information useful to our understanding of restless legs syndrome (RLS), using various imaging techniques to investigate different aspects putatively involved in the pathophysiology of RLS, although there are discrepancies between these findings. The majority of magnetic resonance imaging (MRI) studies using iron-sensitive sequences supports the presence of a diffuse, but regionally variable low brain-iron content, mainly at the level of the substantia nigra, but there is increasing evidence of reduced iron levels in the thalamus. Positron emission tomography (PET) and single positron emission computed tomography (SPECT) findings mainly support dysfunction of dopaminergic pathways involving not only the nigrostriatal but also mesolimbic pathways. None or variable brain structural or microstructural abnormalities have been reported in RLS patients; reports are slightly more consistent concerning levels of white matter. Most of the reported changes were in regions belonging to sensorimotor and limbic/nociceptive networks. Functional MRI studies have demonstrated activation or connectivity changes in the same networks. The thalamus, which includes different sensorimotor and limbic/nociceptive networks, appears to have lower iron content, metabolic abnormalities, dopaminergic dysfunction, and changes in activation and functional connectivity. Summarizing these findings, the primary change could be the reduction of brain iron content, which leads to dysfunction of mesolimbic and nigrostriatal dopaminergic pathways, and in turn to a dysregulation of limbic and sensorimotor networks. Future studies in RLS should evaluate the actual causal relationship among these findings, better investigate the role of neurotransmitters other than dopamine, focus on brain networks by connectivity analysis, and test the reversibility of the different imaging findings following therapy.",
keywords = "Connectivity, Imaging, MRI, Network, Pathophysiology, Restless legs syndrome",
author = "Giovanni Rizzo and Xu Li and Sebastiano Galantucci and Massimo Filippi and Cho, {Yong Won}",
note = "Ricercatore distaccato presso IRCCS a seguito Convenzione esclusiva con Universit{\`a} di Bologna (Rizzo Giovanni).",
year = "2017",
month = "3",
day = "1",
doi = "10.1016/j.sleep.2016.07.018",
language = "English",
volume = "31",
pages = "39--48",
journal = "Sleep Medicine",
issn = "1389-9457",
publisher = "Elsevier",

}

TY - JOUR

T1 - Brain imaging and networks in restless legs syndrome

AU - Rizzo, Giovanni

AU - Li, Xu

AU - Galantucci, Sebastiano

AU - Filippi, Massimo

AU - Cho, Yong Won

N1 - Ricercatore distaccato presso IRCCS a seguito Convenzione esclusiva con Università di Bologna (Rizzo Giovanni).

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Several studies provide information useful to our understanding of restless legs syndrome (RLS), using various imaging techniques to investigate different aspects putatively involved in the pathophysiology of RLS, although there are discrepancies between these findings. The majority of magnetic resonance imaging (MRI) studies using iron-sensitive sequences supports the presence of a diffuse, but regionally variable low brain-iron content, mainly at the level of the substantia nigra, but there is increasing evidence of reduced iron levels in the thalamus. Positron emission tomography (PET) and single positron emission computed tomography (SPECT) findings mainly support dysfunction of dopaminergic pathways involving not only the nigrostriatal but also mesolimbic pathways. None or variable brain structural or microstructural abnormalities have been reported in RLS patients; reports are slightly more consistent concerning levels of white matter. Most of the reported changes were in regions belonging to sensorimotor and limbic/nociceptive networks. Functional MRI studies have demonstrated activation or connectivity changes in the same networks. The thalamus, which includes different sensorimotor and limbic/nociceptive networks, appears to have lower iron content, metabolic abnormalities, dopaminergic dysfunction, and changes in activation and functional connectivity. Summarizing these findings, the primary change could be the reduction of brain iron content, which leads to dysfunction of mesolimbic and nigrostriatal dopaminergic pathways, and in turn to a dysregulation of limbic and sensorimotor networks. Future studies in RLS should evaluate the actual causal relationship among these findings, better investigate the role of neurotransmitters other than dopamine, focus on brain networks by connectivity analysis, and test the reversibility of the different imaging findings following therapy.

AB - Several studies provide information useful to our understanding of restless legs syndrome (RLS), using various imaging techniques to investigate different aspects putatively involved in the pathophysiology of RLS, although there are discrepancies between these findings. The majority of magnetic resonance imaging (MRI) studies using iron-sensitive sequences supports the presence of a diffuse, but regionally variable low brain-iron content, mainly at the level of the substantia nigra, but there is increasing evidence of reduced iron levels in the thalamus. Positron emission tomography (PET) and single positron emission computed tomography (SPECT) findings mainly support dysfunction of dopaminergic pathways involving not only the nigrostriatal but also mesolimbic pathways. None or variable brain structural or microstructural abnormalities have been reported in RLS patients; reports are slightly more consistent concerning levels of white matter. Most of the reported changes were in regions belonging to sensorimotor and limbic/nociceptive networks. Functional MRI studies have demonstrated activation or connectivity changes in the same networks. The thalamus, which includes different sensorimotor and limbic/nociceptive networks, appears to have lower iron content, metabolic abnormalities, dopaminergic dysfunction, and changes in activation and functional connectivity. Summarizing these findings, the primary change could be the reduction of brain iron content, which leads to dysfunction of mesolimbic and nigrostriatal dopaminergic pathways, and in turn to a dysregulation of limbic and sensorimotor networks. Future studies in RLS should evaluate the actual causal relationship among these findings, better investigate the role of neurotransmitters other than dopamine, focus on brain networks by connectivity analysis, and test the reversibility of the different imaging findings following therapy.

KW - Connectivity

KW - Imaging

KW - MRI

KW - Network

KW - Pathophysiology

KW - Restless legs syndrome

UR - http://www.scopus.com/inward/record.url?scp=85013932828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013932828&partnerID=8YFLogxK

U2 - 10.1016/j.sleep.2016.07.018

DO - 10.1016/j.sleep.2016.07.018

M3 - Review article

C2 - 27838239

AN - SCOPUS:85013932828

VL - 31

SP - 39

EP - 48

JO - Sleep Medicine

JF - Sleep Medicine

SN - 1389-9457

ER -